Utah Medical Products
UTMD
64 hedge funds and large institutions have $147M invested in Utah Medical Products in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
10% more capital invested
Capital invested by funds: $133M → $147M (+$13.8M)
8% more funds holding
Funds holding: 59 → 64 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$805K |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$805K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$561K |
| 4 |
B
Bailard
Foster City,
California
|
+$472K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$427K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$1.31M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$915K |
| 3 |
Morgan Stanley
New York
|
-$231K |
| 4 |
Bank of New York Mellon
New York
|
-$202K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
-$170K |
UTMD Hedge Fund Activity: Q4 2015 in Review
64 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2015, worth a combined $147M — up 10% from $133M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new UTMD positions and 2 closed out — a net gain of 5 holders — while 23 added to existing stakes and 17 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $805K. The largest seller was Morgan Dempsey Capital Management, cutting an estimated $1.31M.
- 64 institutional investors held Utah Medical Products (UTMD) as of Q4 2015, up from 59 in Q3 2015.
- Funds reported $147M of Utah Medical Products stock for Q4 2015, up 10% quarter-over-quarter.
- 7 funds opened new Utah Medical Products positions in Q4 2015 and 2 closed out, a net change of +5 holders.
- The largest Utah Medical Products buyer in Q4 2015 was Renaissance Technologies, an estimated $805K added.
- The largest Utah Medical Products seller in Q4 2015 was Morgan Dempsey Capital Management, an estimated $1.31M sold.
Based on aggregated 13F filings for Q4 2015.